Search results

  1. ME/CFS Science Blog

    [Health Rising] ME/CFS Autopsy Study Finds a Wrecked HPA Axis: The 2025 IACFS/ME Conference Report #3

    Good point. This recent PNAS paper argues that the cells likely still exist but have been reprogrammed epigenetically. Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy | PNAS So if that's the case, the question would be: what could be doing something...
  2. ME/CFS Science Blog

    [Health Rising] ME/CFS Autopsy Study Finds a Wrecked HPA Axis: The 2025 IACFS/ME Conference Report #3

    Also think this has the potential to be an important finding. Was anyone besides Cort able to watch the presentation? Suppose there is this major depletion of CRH neurons: wouldn't this be visible on brain scans or is the region too small to be picked up by the tiny brain scan studies that we...
  3. ME/CFS Science Blog

    Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

    For the other mutations listed in the table, the patients were heterozygous so they had only this mutation only once. Suspect that most diseases that they associate with these mutations are recessive: they only manifest if people have two of these mutations without normal back up copy. So not...
  4. ME/CFS Science Blog

    Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

    Am confused because if these identified mutations are truly pathogenic, they would be a major finding and tell us something important about common misdiagnosis of ME/CFS pathology. But looking up mutations for the first gene, KCNJ18, shows that are "seldom pathogenic" as this paper concludes...
  5. ME/CFS Science Blog

    What are the most interesting ME/CFS-studies of 2024?

    I was thinking that next year(s) might give some clearer answers about the antibody-hypothesis. - We already had negative results for Rituximab (which targets CD20), - The Norwegians and possibly also Scheibenbogen will test treatments that target CD38 - DecodeME will re-analyze the HLA region...
  6. ME/CFS Science Blog

    What are the most interesting ME/CFS-studies of 2024?

    No, still re-reading some studies from this year. Thanks. Agree with the 'year of the gene'. Think this has allowed us to make a significant step forward in understanding ME/CFS, although it may still be a long road ahead. Feels a bit like laying the edge pieces of a big puzzle. Perhaps not a...
  7. ME/CFS Science Blog

    Normative data for the 10-min lean test in adults without orthostatic intolerance, 2025, Iftekhar et al.

    EDIT: this is not a new study, the preprint came out in may 2025. There is an interesting new study with normative data for the 10-min lean test in adults without orthostatic intolerance. The data came from 112 participants of the LOCOMOTION study. The average heart rate change was an increase...
  8. ME/CFS Science Blog

    Normative data for the 10-min lean test in adults without orthostatic intolerance, 2025, Iftekhar et al.

    Background: Orthostatic intolerance syndromes such as Orthostatic Hypotension (OH) and Postural Orthostatic Tachycardia Syndrome (PoTS) are common symptoms seen in post-infection conditions and other neurological conditions with autonomic dysfunction. The 10-min Lean Test (LT) is an objective...
  9. ME/CFS Science Blog

    Overview of NIH grants for ME/CFS research

    Did the same exercise again for 2025, and it looks like NIH funding for ME/CFS research keeps falling. There's some ambiguity about which projects to include (is it sufficiently about ME/CFS or not?), and we may have missed one, but the overall trend seems clear...
  10. ME/CFS Science Blog

    The Born Free Protocol

    Thanks. Yeah in the r/aliens community, he made this comment:
  11. ME/CFS Science Blog

    Preprint Genetic Insights into Circulating Complement Proteins in ME/CFS: A Potential Inflammatory Subgroup, 2025, Maya et al

    Only 50 patients from a problematic cohort (which found a prevalence of 2.5%, about 5-10 times as high as similar studies). We have better sources now with DecodeME, so not sure it is worth digging into this.
  12. ME/CFS Science Blog

    Mapping the Complexity of ME/CFS: Evidence for Abnormal Energy Metabolism, Altered Immune Profile and Vascular Dysfunction, 2025, Heng

    Someone also pointed out that fibronectin 1 was increased in this paper in the ME/CFS group (red in the graph below). A previous Prusty paper also reported increased plasma fibronectin 1 Preprint - Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1...
  13. ME/CFS Science Blog

    Mapping the Complexity of ME/CFS: Evidence for Abnormal Energy Metabolism, Altered Immune Profile and Vascular Dysfunction, 2025, Heng

    They found that ME/CFS patients had higher proportions of plasmacytoid dendritic cells (CD11c− CD123+, bottom right in the figure below). This is the immune cell type known to secrete large quantities of type 1 interferon (IFNs) in response to a viral infection as discussed in this thread: (1)...
  14. ME/CFS Science Blog

    STIMULATE-ICP: [...] Phase III, open label, adaptive platform randomised drug trial in [LC]: [Protocol], 2023, Forshaw et al

    There is also already a trial of Colchicine for LC, which found null results: Effectiveness of Colchicine for the Treatment of Long COVID: A Randomized Clinical Trial | Rheumatology | JAMA Internal Medicine | JAMA Network
  15. ME/CFS Science Blog

    STIMULATE-ICP: [...] Phase III, open label, adaptive platform randomised drug trial in [LC]: [Protocol], 2023, Forshaw et al

    Think the article is available at this link: https://www.nature.com/articles/s41591-025-04083-x.pdf The trial in question is called "STIMULATE-ICP" and will test "ivaroxaban, colchicine, famotidine/loratadine". https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272472 An...
  16. ME/CFS Science Blog

    Alterations in gut microbiota and associated metabolites in patients with chronic fatigue syndrome, 2025, Cheng et al

    They found lower butyrate, which is consistent with previous studies: Multi-‘omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients: Cell Host & Microbe Deficient butyrate-producing capacity in the gut microbiome is...
Back
Top Bottom